Hydrogen(H2) treatment for acute erythymatous skin diseases. A report of 4 patients with safety data and a non-controlled feasibility study with H2 concentration measurement on two volunteers

[1]  H. Nawashiro,et al.  Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study , 2011, Medical gas research.

[2]  A. Nakao,et al.  Recent advances in hydrogen research as a therapeutic medical gas , 2010, Free radical research.

[3]  J. Ely,et al.  The generalized rash: part I. Differential diagnosis. , 2010, American family physician.

[4]  J. Raingeaud,et al.  Production of Superoxide Anions by Keratinocytes Initiates P. acnes-Induced Inflammation of the Skin , 2009, PLoS pathogens.

[5]  Yasuo Katayama,et al.  Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals , 2007, Nature Medicine.

[6]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[7]  Ning Zhang,et al.  Edaravone Reduces Early Accumulation of Oxidative Products and Sequential Inflammatory Responses After Transient Focal Ischemia in Mice Brain , 2005, Stroke.

[8]  K. Rokutan,et al.  Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes , 2003, Oncogene.

[9]  T. Kupper,et al.  Inflammatory skin diseases, T cells, and immune surveillance. , 1999, The New England journal of medicine.

[10]  C. Morris,et al.  Skin inflammation: reactive oxygen species and the role of iron. , 1992, The Journal of investigative dermatology.

[11]  M. Levitt Production and excretion of hydrogen gas in man. , 1969, The New England journal of medicine.

[12]  R. Berliner,et al.  Measurement of Local Blood Flow with Hydrogen Gas , 1964, Circulation research.

[13]  J. Treherne The permeability of skin to some non‐electrolytes , 1956, The Journal of physiology.